Sedana Medical AB (publ) updates the schedule for the IsoConDa study.
Regulatory
Sedana Medical AB ("Sedana Medical or the Company") announces that the schedule for patient recruitment in the ongoing Phase 3 IsoConDa study is likely to be extended.